Patent Grant
7695979
There are many systems and devices available for detecting a wide variety of analytes in various media. Many of the prior systems and devices are, however, relatively expensive and require a trained technician to perform the test. A need has been recognized in the art for biosensor systems that are easy and inexpensive to manufacture, and capable of reliable and sensitive detection of analytes. Reference is made, for example, to U.S. Pat. Nos. 5,922,550; 6,060,256; and 6,221,579 B1.
Various advances have been made in the industry for producing biosensors. For example, U.S. Pat. No. 5,512,131 to Kumar, et al., describes a device that includes a polymer substrate having a metal coating. An analyte specific receptor layer is stamped onto the coated substrate. A diffraction pattern is generated when an analyte binds to the device. A visualization device, such as a spectrometer, is then used to determine the presence of the diffraction pattern. A drawback to this type of device is, however, the fact that the diffraction pattern is not discernible by the naked eye and, thus, a complex visualization device is needed to view the diffraction pattern. Also, the device is generally not able to detect smaller analytes that do not produce a noticeable diffraction pattern.
U.S. Pat. No. 5,482,830 to Bogart, et al., describes a device that includes a substrate which has an optically active surface exhibiting a first color in response to light impinging thereon. This first color is defined as a spectral distribution of the emanating light. The substrate also exhibits a second color which is different from the first color. The second color is exhibited in response to the same light when the analyte is present on the surface. The change from one color to another can be measured either by use of an instrument, or by the naked eye. A drawback with the device is, however, the relatively high cost of the device and problems associated with controlling the various layers that are placed on the wafer substrate.
Contact printing techniques have been explored for producing biosensors having a self-assembling monolayer. U.S. Pat. No. 5,922,550 describes a biosensor having a metalized film upon which is printed (contact printed) a specific predetermined pattern of an analyte-specific receptor. The receptor materials are bound to the self-assembling monolayer and are specific for a particular analyte or class of analytes. Attachment of a target analyte that is capable of scattering light to select areas of the metalized plastic film upon which the receptor is printed causes diffraction of transmitted and/or reflected light. A diffraction image is produced that can be easily seen with the eye or, optionally, with a sensing device. U.S. Pat. No. 6,060,256 describes a similar device having a metalized film upon which is printed a specific predetermined pattern of analyte-specific receptor. The '256 patent is not limited to self-assembling monolayers, but teaches that any receptor which can be chemically coupled to a surface can be used. The invention of the '256 patent uses methods of contact printing of patterned monolayers utilizing derivatives of binders for microorganisms. One example of such a derivative is a thiol. The desired binding agent can be thiolated antibodies or antibody fragments, proteins, nucleic acids, sugars, carbohydrates, or any other functionality capable of binding an analyte. The derivatives are chemically bonded to metal surfaces such as metalized polymer films, for example via a thiol.
A potential issue of the contact printing techniques described above for producing diffraction-based biosensors is the possibility of contamination from the print surface (i.e., stamp) during the printing process. Also, there is the possibility of uneven application or inking of the substances due to pressure and contact variations inherent in the process, as well as surface energy variations.
The present invention relates to a biosensor system that is easy and inexpensive to manufacture, is capable of reliable and sensitive detection of analytes, and avoids possible drawbacks of conventional microcontact printing techniques.
Objects and advantages of the invention will be set forth in part in the following description, or may be obvious from the description, or may be learned through practice of the invention.
The present invention provides a relatively inexpensive yet sensitive biosensor device, a method for producing such biosensor devices, and a method for detecting analytes of interest present in a medium.
The biosensor includes a substrate containing a photo-reactive agent. The agent may be applied generally uniformly as a layer over an entire surface of the substrate member. Alternatively, the substrate may contain the agent as an integral component thereof. The photo-reactive agent may be, for example, a photo-acid or photo-oxidant. The agent may be in solution in a “transparent” polymer, for example PVC, polystyrene, and the like, and a thin film of the solution may be applied on the substrate member by, for example, a spin-coating process. In alternate embodiments, the agent may be embedded or polymerized in the substrate. A special plasticizer may incorporate the agent. The substrate may be formed of a material that produces an acid, base, or oxidant, upon exposure to a particular stimulus (e.g. light).
The substrate may be any one of a wide variety of suitable materials, including plastics, metal coated plastics and glass, functionalized plastics and glass, silicon wafers, foils, glass, etc.
The photo-reactive agent may be applied as a layer in a light-protected environment by any number of known techniques, including dipping, spraying, rolling, spin coating and any other technique wherein the layer can be applied generally uniformly over the entire test surface of the substrate. The invention also includes contact printing methods of applying the photo-reactive agent layer.
A layer containing a receptive material (e.g., biomolecules) is then applied over the photo-reactive agent layer also in a light-protected environment. The receptive material layer may be applied by any number of known techniques, including dipping, spraying, rolling, spin coating and any other technique wherein the layer can be applied generally uniformly over the entire test surface of the substrate. The invention also includes contact printing methods of applying the receptive material layer, as long as such methods are conducted in a manner to prevent inconsistent inking and contamination from contact during the coating process.
The receptive material layer is then defined into a pattern of active and inactive areas of receptive material by placing a mask over the substrate and subsequently irradiating the substrate with an energy source sufficient to activate the photo-reactive agent in the exposed or unshielded areas of the mask. Activation of the photo-reactive agent results in denaturing of the overlying biomolecules in the exposed areas. The receptive material is thus “deactivated” to the extent that it can no longer bind with conjugate ligands, including the analyte of interest.
The mask may include any desired pattern of protected or shielded areas and exposed areas (e.g., blank, transparent, or translucent areas, as well as holes or openings in the mask structure). The exposed areas of the mask define a pattern of inactive areas of the receptive material and the shielded areas of the mask define a pattern of active receptive material areas. The mask thus serves to shield an area of the receptive material layer and to expose at least one adjacent area to the irradiating energy source for activating the underlying photo-reactive agent.
It should be appreciated that the invention is not limited to any particular pattern defined by the mask. Virtually any number and combination of exposed shapes or openings are possible. In one particular embodiment, the pattern is defined by about 10 micron diameter pixels at a spacing of about 5 microns over the test surface of the substrate.
The photo-reactive agent and receptive material layers are irradiated with an energy source selected particularly for activating the specific type of photo-reactive agent. The invention is not limited to any particular energy source. For example, the energy source may be a light source, e.g., an ultraviolet (UV) light source, an electron beam, a radiation source, etc.
Upon subsequent exposure of the biosensor to a medium containing an analyte of interest, the analyte binds to the receptive material in the active areas. The biosensor will then diffract transmitted light in a diffraction pattern corresponding to the active areas. The diffraction pattern may be visible to the naked eye or, optionally, viewed with a sensing device.
In the case where an analyte does not scatter visible light because the analyte is too small or does not have an appreciable refractive index difference compared to the surrounding medium, a diffraction-enhancing element, such as polymer microparticles, may be used. These micorparticles are coated with a binder or receptive material that also specifically binds to the analyte. Upon subsequent coupling of the analyte to both the patterned biomolecules in the receptive material layer as well as the microparticles, a diffraction image is produced which can be easily seen with the eye or, optionally, with a sensing device.
By “diffraction” it is meant the phenomenon, observed when waves are obstructed by obstacles, of the disturbance spreading beyond the limits of the geometrical shadow of the object. The effect is marked when the size of the object is of the same order as the wavelength of the waves. In the present invention, the obstacles are analytes (with or without or attached microparticles) and the waves are light waves.
In another embodiment of the present invention, nutrients for a specific class of microorganisms can be incorporated into the receptive material layer. In this way, very low concentrations of microorganisms can be detected by first contacting the biosensor of the present invention with the nutrients incorporated therein and then incubating the biosensor under conditions appropriate for the growth of the bound microorganism. The microorganism is allowed to grow until there are enough organisms to form a diffraction pattern.
The present invention provides a low-cost, disposable biosensor which can be mass produced. The biosensors of the present invention can be produced as a single test for detecting an analyte or it can be formatted as a multiple test device. The uses for the biosensors of the present invention include, but are not limited to, detection of chemical or biological contamination in garments, such as diapers, the detection of contamination by microorganisms in prepacked foods such as meats, fruit juices or other beverages, and the use of the biosensors of the present invention in health diagnostic applications such as diagnostic kits for the detection of hormones, proteins, antigens, nucleic acids, microorganisms, and blood constituents. It should be appreciated that the present invention is not limited to any particular use or application.
These and other features and advantages of the present invention will become apparent after a review of the following detailed description of the disclosed embodiments.
The invention will now be described in detail with reference to particular embodiments thereof. The embodiments are provided by way of explanation of the invention, and not meant as a limitation of the invention. For example, features described or illustrated as part of one embodiment may be used with another embodiment to yield still a further embodiment. It is intended that the present invention include these and other modifications and variations as come within the scope and spirit of the invention.
The present invention features improved biosensing devices, and methods for using such biosensing devices, for detecting and quantifying the presence or amount of an analyte of interest within a medium. The analytes that can be detected by the present invention include, but are not limited to, microorganisms such as bacteria, yeasts, fungi and viruses. The biosensing devices according to the invention are relatively inexpensive and have advantages over conventional micro-printed biosensors.
The present invention comprises, in broad terms, a process of defining an active pattern of analyte-specific receptive material on a substrate surface by photo-masking the substrate. A photo-reactive agent is incorporated with the substrate member, for example by spin-coating a solution containing the agent onto the substrate member. Alternatively, the agent may be embedded or polymerized in the substrate. In another embodiment, the substrate may be formed in part or entirely of a photo-reactive substance. For example, the substrate may be PVC (polyvinyl chloride) which will produce HCL (hydrochloric acid) upon exposure to UV light. Polyamine will produce a base upon exposure to UV light. A generally uniform coating of the receptive material is then applied to the substrate surface over the photo-reactive agent. A mask is placed over the substrate, and the mask and substrate combination is irradiated with an energy source specifically selected to activate the photo-reactive agent. In its basic form, the “mask” serves to shield at least one area or section of the substrate member from the irradiating energy source and to expose at least one adjacent section to the energy source. For example, the mask may be a generally transparent or translucent blank (e.g., a strip of material) having any pattern of shielded regions printed or otherwise defined thereon. The exposed unshielded regions of the mask correspond to the exposed areas of the substrate member. Alternatively, the mask may simply be a single object placed upon the substrate. The area under the object would be shielded and thus define an active area of the receptive material, and the area around the object would be exposed to the energy source and thus define an area of inactive receptive material. Alternatively, the object may have any pattern of openings defined therethrough corresponding to the exposed areas.
As mentioned, the energy source is selected so that the exposed photo-reactive agent is activated and thus denatures the overlying biomolecules, thereby rendering the receptive material inactive in the exposed regions. Specifically, the activated photo-reactive agent may be any one of a number of substances, such asdiaryliodonium salts, triarylsulfonium salts, diazosulfonates, bromobisphenol A, certain Cl containing polymers, acid or base producing polymers, dialkylphenacylsulfonium salts, etc., or photo-oxidants such as ZnO, TiO2, and certain copper and ruthenium complexes. In one particular embodiment, the agent is a photo-acid, such as Triphenylsulfonium triflate, (4-iodophenyl) diphenylsulfonium triflate, Diphenyliodonium p-toluenesulfonate, Bis(4-t-butylphenyl) iodonium p-toluenesulfonate, Bis(4-t-butylphenyl) iodonium triflate, and Tris(4-t-butylphenyl) sulfonium triflate. In another embodiment, the agent may be a photo-oxidant, such as ZnO; TiO2; Cu[2,9-diphenyl-1-10-phenanthroline]2+ in the presence of nitrobenzylbromide; and Ru[2,2′-bipyridine]32+ in the presence of Co[(NH3)5Cl]2+. The photo-reactive agent in the regions shielded by the mask remains “unactivated.” Thus, upon removal of the mask, a pattern of active and inactive receptive material areas are defined on the substrate member. It should be understood that “pattern” includes as few as one active area and one inactive area.
Upon subsequent exposure of the biosensor to a medium containing the analyte of interest, such analyte will bind to the biomolecules in the active areas. The analyte results in diffraction of transmitted and/or reflected light in a visible diffraction pattern corresponding to the active areas. As discussed in greater detail below, an enhancer may be used for enhancing diffraction from extremely small analytes.
The analytes that are contemplated as being detected using the present invention include, but are not limited to, bacteria; yeasts; fungi; viruses; rheumatoid factor; antibodies, including, but not limited to IgG, IgM, IgA, IgD, and IgE antibodies; carcinoembryonic antigen; streptococcus Group A antigen; viral antigens; antigens associated with autoimmune disease, PSA (prostate specific antigen) and CRP (C-reactive protein) antigens; allergens; tumor antigens; streptococcus Group B antigen; HIV I or HIV II antigen; or host response (antibodies) to these and other viruses; antigens specific to RSV or host response (antibodies) to the virus; antigen; enzyme; hormone; polysaccharide; protein; lipid; carbohydrate; drug or nucleic acid; Salmonella species; Candida species, including, but not limited to Candida albicans and Candida tropicalis; Neisseria meningitides groups A, B, C, Y and W sub 135, Streptococcus pneumoniae; E. coli; Haemophilus influenza type A/B; an antigen derived from microorganisms; a hapten; a drug of abuse; a therapeutic drug; an environmental agent; and antigens specific to Hepatitis. In broad terms, the “analyte of interest” may be thought of as any agent whose presence or absence from a biological sample is indicative of a particular health state or condition.
It is also contemplated that nutrients for a specific class of microorganism can be incorporated into the receptive material layer. In this way, very low concentrations of microorganisms can be detected by exposing the biosensor of the present invention with the nutrients incorporated therein to the suspect medium and then incubating the biosensor under conditions appropriate for the growth of the bound microorganism. The microorganisms are allowed to grow until there are enough organisms to form a diffraction pattern. Of course, in some cases, the microorganism is present or can multiply enough to form a diffraction pattern without the presence of a nutrient in the active receptive material areas.
The receptive material is characterized by an ability to specifically bind the analyte or analytes of interest. The variety of materials that can be used as receptive material is limited only by the types of material which will combine selectively (with respect to any chosen sample) with a secondary partner. Subclasses of materials which fall in the overall class of receptive materials include toxins, antibodies, antibody fragments, antigens, hormone receptors, parasites, cells, haptens, metabolites, allergens, nucleic acids, nuclear materials, autoantibodies, blood proteins, cellular debris, enzymes, tissue proteins, enzyme substrates, coenzymes, neuron transmitters, viruses, viral particles, microorganisms, proteins, polysaccharides, chelators, drugs, aptamers, peptides, and any other member of a specific binding pair. This list only incorporates some of the many different materials that can be coated onto the substrate surface to produce a thin film assay system. Whatever the selected analyte of interest is, the receptive material is designed to bind specifically with the analyte of interest.
The matrix or medium containing the analyte of interest may be a liquid, a solid, or a gas, and can include a bodily fluid such as mucous, saliva, urine, fecal material, tissue, marrow, cerebral spinal fluid, serum, plasma, whole blood, sputum, buffered solutions, extracted solutions, semen, vaginal secretions, pericardial, gastric, peritoneal, pleural, or other washes and the like. The analyte of interest may be an antigen, an antibody, an enzyme, a DNA fragment, an intact gene, a RNA fragment, a small molecule, a metal, a toxin, an environmental agent, a nucleic acid, a cytoplasm component, pili or flagella component, protein, polysaccharide, drug, or any other material. For example, receptive material for bacteria may specifically bind a surface membrane component, protein or lipid, a polysaccharide, a nucleic acid, or an enzyme. The analyte which is specific to the bacteria may be a polysaccharide, an enzyme, a nucleic acid, a membrane component, or an antibody produced by the host in response to the bacteria. The presence or absence of the analyte may indicate an infectious disease (bacterial or viral), cancer or other metabolic disorder or condition. The presence or absence of the analyte may be an indication of food poisoning or other toxic exposure. The analyte may indicate drug abuse or may monitor levels of therapeutic agents.
One of the most commonly encountered assay protocols for which this technology can be utilized is an immunoassay. However, the general considerations apply to nucleic acid probes, enzyme/substrate, and other ligand/receptor assay formats. For immunoassays, an antibody may serve as the receptive material or it may be the analyte of interest. The receptive material, for example an antibody or an antigen, must form a stable, relatively dense, reactive layer on the substrate surface of the test device. If an antigen is to be detected and an antibody is the receptive material, the antibody must be specific to the antigen of interest; and the antibody (receptive material) must bind the antigen (analyte) with sufficient avidity that the antigen is retained at the test surface. In some cases, the analyte may not simply bind the receptive material, but may cause a detectable modification of the receptive material to occur. This interaction could cause an increase in mass at the test surface or a decrease in the amount of receptive material on the test surface. An example of the latter is the interaction of a degradative enzyme or material with a specific, immobilized substrate. In this case, one would see a diffraction pattern before interaction with the analyte of interest, but the diffraction pattern would disappear if the analyte were present. The specific mechanism through which binding, hybridization, or interaction of the analyte with the receptive material occurs is not important to this invention, but may impact the reaction conditions used in the final assay protocol.
In addition to producing a simple diffraction image, patterns of analytes can be such as to allow for the development of a holographic sensing image and/or a change in visible color. Thus, the appearance of a hologram or a change in an existing hologram will indicate a positive response. The pattern made by the diffraction of the transmitted light can be any shape including, but not limited to, the transformation of a pattern from one pattern to another upon binding of the analyte to the receptive material. In particularly preferred embodiments, the diffraction pattern becomes discernible in less than one hour after contact of the analyte with the biosensing device of the present invention.
The diffraction grating which produces the diffraction of light upon interaction with the analyte must have a minimum periodicity of about ½ the wavelength and a refractive index different from that of the surrounding medium. Very small analytes, such as viruses or molecules, can be detected indirectly by using a larger, “diffraction-enhancing element,” such as a micro-particle, that is specific for the small analyte. One embodiment in which the small analyte can be detected comprises coating the enhancing particle, such as a latex bead or polystyrene bead, with a receptive material, such as an antibody, that specifically binds to the analyte of interest. Particles that can be used in the present invention include, but are not limited to, glass, cellulose, synthetic polymers or plastics, latex, polystyrene, polycarbonate, proteins, bacterial or fungal cells, silica, cellulose acetate, carbon, and the like. The particles are desirably spherical in shape, but the structural and spatial configuration of the particles is not critical to the present invention. For instance, the particles could be slivers, ellipsoids, cubes, random shape and the like. A desirable particle size ranges from a diameter of approximately 0.1 micron to 50 microns, desirably between approximately 0.1 micron and 2.0 microns. The composition of the particle is not critical to the present invention.
Desirably, the receptive material layer on the substrate will specifically bind to an epitope on the analyte that is different from the epitope used in the binding to the enhancing particle. Thus, for detecting a small analyte, such as viral particles, in a medium, the medium is first exposed to the latex particles having the virus-specific receptive material thereon. The small analytes of interest in the medium will bind to the latex particles. Then, the latex particles are optionally washed and exposed to the biosensor film with the pattern of active receptive material areas containing the virus-specific antibodies. The antibodies then bind to the viral particles on the latex bead thereby immobilizing the latex beads in the same pattern as the active areas on the film. Because the bound latex beads will cause diffraction of the visible light, a diffraction pattern is formed, indicating the presence of the viral particle in the liquid. Other combinations using diffraction enhancing particles are described, for example, in U.S. Pat. No. 6,221,579 incorporated herein for all purposes.
Any one of a wide variety of materials may serve as the substrate to which the receptive material is applied. Such materials are well known to those skilled in the art. For example, the substrate may be formed of any one of a number of suitable plastics, metal coated plastics and glass, functionalized plastics and glass, silicon wafers, foils, glass, acid or base producing polymers, etc. It should be appreciated that, if the photo-reactive agent is a photo-acid, the substrate would not be metal or metal coated. Thermoplastic films have been shown to be quite suitable. Such films include, but are not limited to, polymers such as: polyethylene-terephthalate (MYLAR®), acrylonitrile-butadiene-styrene, acrylonitrile-methyl acrylate copolymer, cellophane, cellulosic polymers such as ethyl cellulose, cellulose acetate, cellulose acetate butyrate, cellulose propionate, cellulose triacetate, cellulose triacetate, polyethylene, polyethylene-vinyl acetate copolymers, ionomers (ethylene polymers) polyethylene-nylon copolymers, polypropylene, methyl pentene polymers, polyvinyl fluoride, and aromatic polysulfones. Preferably, the plastic film has an optical transparency of greater than 80 percent. Other suitable thermoplastics and suppliers may be found, for example, in reference works such as the Modern Plastics Encyclopedia (McGraw-Hill Publishing Co., New York 1923-1996).
In one embodiment of the invention wherein the photo-reactive agent is a photo-oxidant, the thermoplastic film may have a metal coating. The film with metal coating thereon may have an optical transparency of between approximately 5 percent and 95 percent. A more desired optical transparency for the thermoplastic film used in the present invention is between approximately 20 percent and 80 percent. In a desired embodiment of the present invention, the thermoplastic film has at least an approximately 80 percent optical transparency, and the thickness of the metal coating is such as to maintain an optical transparency greater than about 20 percent, so that diffraction patterns can be produced by either reflected or transmitted light. This corresponds to a metal coating thickness of about 20 nanometers. However, in other embodiments of the invention, the metal thickness may be between approximately 1 nanometer and 1000 nanometers.
The preferred metal for deposition on the film is gold. However, silver, aluminum, chromium, copper, iron, zirconium, platinum, titanium, and nickel, as well as oxides of these metals, may be used. Chromium oxide can be used to make metalized layers.
The receptive material may be applied to the substrate over the photo-reactive layer by any conventional method. The material is applied so that it generally uniformly covers an entire (i.e. upper) surface of the substrate. Non-contact methods for applying the receptive material may be desired so as to eliminate the possibility of contamination by contact printing device. Such non-contact methods include, but are not limited to, dipping, spraying, rolling, spin coating, and any other technique wherein the receptive material layer can be applied generally uniformly over the entire test surface of the substrate. Simple physisorption can occur on many materials, such as polystyrene, glass, nylon, or other materials well known to those skilled in the art. One particular embodiment of immobilizing the analyte-specific receptive material layer involves molecular attachment, such as that possible between thiol or disulfide-containing compounds and gold. Typically, a gold coating of about 5 to about 2000 nanometers thick is supported on a silicon wafer, glass, or polymer film (such as a MYLAR® film). The analyte-specific receptor attaches to the gold surface during immersion or spraying of a solution of the receptive material.
Although not preferred, the invention also includes contact printing methods of applying the receptive material. The technique selected should minimize the amount of receptive material required for coating a large number of test surfaces and maintain the stability/functionality of the receptive material during application. The technique should also apply or adhere the receptive material to the substrate in a uniform and reproducible fashion.
It is also contemplated that the receptive material layer may be formed on the substrate as a self-assembling monolayers of alkanethiolates, carboxylic acids, hydroxamic acids, and phosphonic acids on metalized thermoplastic films. The self-assembling monolayers have receptive material bound thereto. Reference is made to U.S. Pat. No. 5,922,550 for a more detailed description of such self-assembling monolayers and methods for producing the monolayers. The '550 patent is incorporated herein in its entirety for all purposes.
The mask may be formed of any suitable material that shields the underlying portion of the substrate from the irradiating energy source. A material that has proven useful for defining patterns of active and inactive receptive material regions on a gold-plated MYLAR® film coated with an antibody solution is a transparent or translucent polymer film (such as MYLAR®) having a pattern of blocked or protected regions printed thereon. This type of mask is useful for light sources (irradiating energy source) with a wavelength equal to or greater than about 330 nanometers. For light sources having a wavelength below about 330 nanometers, a quartz or fused silica mask having chrome plated blocked regions defined thereon may be used. It may be desired to select a hole pattern and size so as to maximize the visible diffraction contrast between the active and inactive regions. It has been found suitable if the active regions are defined as generally circular with a diameter of about 10 microns and spaced from each other by about 5 microns.
Any suitable energy source may be selected for irradiating the mask and substrate combination. An energy source is selected particularly for activating the specific type of photo-reactive agent. The energy source may be, for example, a light source, e.g., an ultraviolet (UV) light source, an electron beam, a radiation source, etc. In one particular embodiment, the photo-reactive agent is a photo-acid or a photo-oxidant, such as Triphenyulsulfonium triflate or TiO2, respectively, and the activating energy source is a UV light source. The sensor is exposed to the light source for a period of time sufficient for the photo-reactive agent to be activated and thus render the receptive material in the exposed areas inactive. Depending on the particular type of photo-reactive agent, light of a proper wavelength generates either an acid, base, or an oxidant in the illuminated regions. These relatively large localized concentrations of an acid, base, or oxidant serve to denature the proteins in the receptive material. The “denaturing” occurs either through acid-catalyzed hydrolysis of the antibody, pH-induced conformational changes, or via oxidation/radical formation of/on the antibody, or a combination of such factors. In the case of chlorinated polymers, irradiation generates HCl, and the localized increase in acid concentration serves to denature the antibody. It should be appreciated that the invention is not limited to any particular type of light or activating energy source or exposure times. The type of light (e.g., wavelength) and exposure times may vary depending on the particular type of photo-reactive agent. Other suitable energy sources may include tuned lasers, electron beams, various types of radiation beams including gamma and X-ray sources, various intensities and wavelengths of light including light beams of sufficient magnitude at the microwave and below wavelengths, etc. Care should be taken that the energy source does not damage (e.g., melt) the underlying substrate or mask.
The biosensors according to the invention have a wide range of uses in any number of fields. The uses for the biosensors of the present invention include, but are not limited to, detection of chemical or biological contamination in garments, such as diapers, generally the detection of contamination by microorganisms in prepacked foods such as meats, fruit juices or other beverages, and the use of the biosensors of the present invention in health diagnostic applications such as diagnostic kits for the detection of proteins, hormones, antigens, nucleic acids, DNA, microorganisms, and blood constituents. The present invention can also be used on contact lenses, eyeglasses, window panes, pharmaceutical vials, solvent containers, water bottles, band-aids, wipes, and the like to detect contamination. In one embodiment, the present invention is contemplated in a dipstick form in which the patterned substrate is mounted at the end of the dipstick. In use the dipstick is dipped into the liquid in which the suspected analyte may be present and allowed to remain for several minutes. The dipstick is then removed and then, either a light is projected through the substrate or the substrate is observed with a light reflected from the substrate. If a diffraction pattern is observed, then the analyte is present in the liquid.
In another embodiment of the present invention, a multiple analyte test is constructed on the same support. A strip may be provided with several patterned substrate sections. Each section has a different receptive material that is different for different analytes. It can be seen that the present invention can be formatted in any array with a variety of patterned substrates thereby allowing the user of the biosensor device of the present invention to detect the presence of multiple analytes in a medium using a single test.
In yet another embodiment of the present invention, the biosensor can be attached to an adhesively backed sticker or decal which can then be placed on a hard surface or container wall. The biosensor can be placed on the inside surface of a container such as a food package or a glass vial. The biosensor can then be visualized to determine whether there is microbial contamination.
It should be understood that the invention includes various other embodiments, modifications, and equivalents to the examples described herein which, after reading the description of the invention, may become apparent to those skilled in the art without departing from the scope and spirit of the present invention.
The present application is a divisional application of U.S. patent application Ser. No. 10/139,013 having a filing date of May 3, 2002 and relates generally to the field of detecting analytes in a medium, and more particularly to a process for preparing analyte-specific diagnostic sensors to indicate the presence of the analyte in a medium in, for example, a diffraction/holography format.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3641354 | De Ment | Feb 1972 | A |
| 4011009 | Lama et al. | Mar 1977 | A |
| 4274706 | Tangonan | Jun 1981 | A |
| 4312228 | Wohltjen | Jan 1982 | A |
| 4330175 | Fjuii et al. | May 1982 | A |
| 4363874 | Greenquist | Dec 1982 | A |
| 4399686 | Kindlund et al. | Aug 1983 | A |
| 4416505 | Dickson | Nov 1983 | A |
| 4442204 | Greenquist et al. | Apr 1984 | A |
| 4477158 | Pollock et al. | Oct 1984 | A |
| 4480042 | Craig et al. | Oct 1984 | A |
| 4528260 | Kane | Jul 1985 | A |
| 4534356 | Papadakis | Aug 1985 | A |
| 4537861 | Elings et al. | Aug 1985 | A |
| 4552458 | Lowne | Nov 1985 | A |
| 4561286 | Sekler et al. | Dec 1985 | A |
| 4562157 | Lowe et al. | Dec 1985 | A |
| 4587213 | Malecki | May 1986 | A |
| 4596697 | Ballato | Jun 1986 | A |
| 4614723 | Schmidt et al. | Sep 1986 | A |
| 4632559 | Brunsting | Dec 1986 | A |
| 4647544 | Nicoli et al. | Mar 1987 | A |
| 4661235 | Krull et al. | Apr 1987 | A |
| 4690715 | Allara et al. | Sep 1987 | A |
| 4698262 | Schwartz et al. | Oct 1987 | A |
| 4776944 | Janata et al. | Oct 1988 | A |
| 4812221 | Madou et al. | Mar 1989 | A |
| 4815843 | Tiefenthaler et al. | Mar 1989 | A |
| 4818710 | Sutherland et al. | Apr 1989 | A |
| 4837715 | Ungpiyakul et al. | Jun 1989 | A |
| 4842633 | Kuribayashi et al. | Jun 1989 | A |
| 4842783 | Blaylock | Jun 1989 | A |
| 4844613 | Batchelder et al. | Jul 1989 | A |
| 4851816 | Macias et al. | Jul 1989 | A |
| 4876208 | Gustafson et al. | Oct 1989 | A |
| 4877747 | Stewart | Oct 1989 | A |
| 4882288 | North et al. | Nov 1989 | A |
| 4895017 | Pyke et al. | Jan 1990 | A |
| 4917503 | Bhattacharjee | Apr 1990 | A |
| 4931384 | Layton et al. | Jun 1990 | A |
| 4992385 | Godfrey | Feb 1991 | A |
| 4999489 | Huggins | Mar 1991 | A |
| RE33581 | Nicoli et al. | Apr 1991 | E |
| 5023053 | Finlan | Jun 1991 | A |
| 5035863 | Finlan et al. | Jul 1991 | A |
| 5055265 | Finlan | Oct 1991 | A |
| 5057560 | Mueller | Oct 1991 | A |
| 5063081 | Cozzette et al. | Nov 1991 | A |
| 5064619 | Finlan | Nov 1991 | A |
| 5071248 | Tiefenthaler et al. | Dec 1991 | A |
| 5076094 | Frye et al. | Dec 1991 | A |
| 5089387 | Tsay et al. | Feb 1992 | A |
| 5096671 | Kane et al. | Mar 1992 | A |
| 5114676 | Leiner et al. | May 1992 | A |
| 5124254 | Hewlins et al. | Jun 1992 | A |
| 5134057 | Kuypers et al. | Jul 1992 | A |
| 5137609 | Manian et al. | Aug 1992 | A |
| 5143854 | Pirrung et al. | Sep 1992 | A |
| 5152758 | Kaetsu et al. | Oct 1992 | A |
| 5155791 | Hsiung | Oct 1992 | A |
| 5182135 | Giesecke et al. | Jan 1993 | A |
| 5189902 | Groeninger | Mar 1993 | A |
| 5196350 | Backman et al. | Mar 1993 | A |
| 5225935 | Watanabe et al. | Jul 1993 | A |
| 5235238 | Nomura et al. | Aug 1993 | A |
| 5238815 | Higo et al. | Aug 1993 | A |
| 5242828 | Bergstrom et al. | Sep 1993 | A |
| 5262299 | Evangelista et al. | Nov 1993 | A |
| 5268306 | Berger et al. | Dec 1993 | A |
| 5280548 | Atwater et al. | Jan 1994 | A |
| 5304293 | Tierney et al. | Apr 1994 | A |
| 5310686 | Sawyers et al. | May 1994 | A |
| 5315436 | Lowenhar et al. | May 1994 | A |
| 5321492 | Detwiler et al. | Jun 1994 | A |
| 5327225 | Bender et al. | Jul 1994 | A |
| 5334303 | Muramatsu et al. | Aug 1994 | A |
| 5352582 | Lichtenwalter et al. | Oct 1994 | A |
| 5369717 | Attridge | Nov 1994 | A |
| 5374563 | Maule | Dec 1994 | A |
| 5376255 | Gumbrecht et al. | Dec 1994 | A |
| 5378638 | Deeg et al. | Jan 1995 | A |
| 5389534 | von Gentzkow et al. | Feb 1995 | A |
| 5402075 | Lu et al. | Mar 1995 | A |
| 5404756 | Briggs et al. | Apr 1995 | A |
| 5415842 | Maule | May 1995 | A |
| 5418136 | Miller et al. | May 1995 | A |
| 5424220 | Goerlach-Graw et al. | Jun 1995 | A |
| 5430815 | Shen et al. | Jul 1995 | A |
| 5436161 | Bergstrom et al. | Jul 1995 | A |
| 5451683 | Barrett et al. | Sep 1995 | A |
| 5455178 | Fattinger | Oct 1995 | A |
| 5455475 | Josse et al. | Oct 1995 | A |
| 5464741 | Hendrix | Nov 1995 | A |
| 5468606 | Bogart et al. | Nov 1995 | A |
| 5478527 | Gustafson et al. | Dec 1995 | A |
| 5482830 | Bogart et al. | Jan 1996 | A |
| 5482867 | Barrett et al. | Jan 1996 | A |
| 5489678 | Fodor et al. | Feb 1996 | A |
| 5489988 | Ackley et al. | Feb 1996 | A |
| 5492840 | Malmqvist et al. | Feb 1996 | A |
| 5496701 | Pollard-Knight | Mar 1996 | A |
| 5510481 | Bednarski et al. | Apr 1996 | A |
| 5510628 | Georger, Jr. et al. | Apr 1996 | A |
| 5512131 | Kumar et al. | Apr 1996 | A |
| 5514501 | Tarlov | May 1996 | A |
| 5514559 | Markert-Hahn et al. | May 1996 | A |
| 5516635 | Ekins et al. | May 1996 | A |
| 5518689 | Dosmann et al. | May 1996 | A |
| 5527711 | Tom-Moy et al. | Jun 1996 | A |
| 5552272 | Bogart | Sep 1996 | A |
| 5554541 | Malmqvist et al. | Sep 1996 | A |
| 5569608 | Sommer | Oct 1996 | A |
| 5573909 | Singer et al. | Nov 1996 | A |
| 5580697 | Keana et al. | Dec 1996 | A |
| 5580921 | Stepp et al. | Dec 1996 | A |
| 5585279 | Davidson | Dec 1996 | A |
| 5589401 | Hansen et al. | Dec 1996 | A |
| 5591581 | Massey et al. | Jan 1997 | A |
| 5599668 | Stimpson et al. | Feb 1997 | A |
| 5620850 | Bamdad et al. | Apr 1997 | A |
| 5637509 | Hemmilä et al. | Jun 1997 | A |
| 5643681 | Voorhees et al. | Jul 1997 | A |
| 5658443 | Yamamoto et al. | Aug 1997 | A |
| 5677196 | Herron et al. | Oct 1997 | A |
| 5731147 | Bard et al. | Mar 1998 | A |
| 5780251 | Klainer et al. | Jul 1998 | A |
| 5811526 | Davidson | Sep 1998 | A |
| 5814565 | Reichert et al. | Sep 1998 | A |
| 5827748 | Golden | Oct 1998 | A |
| 5830762 | Weindel | Nov 1998 | A |
| 5832165 | Reichert et al. | Nov 1998 | A |
| 5843692 | Phillips et al. | Dec 1998 | A |
| 5863740 | Kientsch-Engel et al. | Jan 1999 | A |
| 5910940 | Guerra | Jun 1999 | A |
| 5922537 | Ewart et al. | Jul 1999 | A |
| 5922550 | Everhart et al. | Jul 1999 | A |
| 5922615 | Nowakowski et al. | Jul 1999 | A |
| 5965305 | Ligler et al. | Oct 1999 | A |
| 6030840 | Mullinax et al. | Feb 2000 | A |
| 6048623 | Everhart et al. | Apr 2000 | A |
| 6060237 | Nygren et al. | May 2000 | A |
| 6060256 | Everhart et al. | May 2000 | A |
| 6084683 | Bruno et al. | Jul 2000 | A |
| 6107038 | Choudhary et al. | Aug 2000 | A |
| 6113855 | Buechler | Sep 2000 | A |
| 6136611 | Saaski et al. | Oct 2000 | A |
| 6171780 | Pham et al. | Jan 2001 | B1 |
| 6180288 | Everhart et al. | Jan 2001 | B1 |
| 6182571 | Jolliffe et al. | Feb 2001 | B1 |
| 6200820 | Hansen et al. | Mar 2001 | B1 |
| 6203758 | Marks et al. | Mar 2001 | B1 |
| 6221579 | Everhart et al. | Apr 2001 | B1 |
| 6287783 | Maynard et al. | Sep 2001 | B1 |
| 6287871 | Herron et al. | Sep 2001 | B1 |
| 6297060 | Nowakowski et al. | Oct 2001 | B1 |
| 6312961 | Voirin et al. | Nov 2001 | B1 |
| 6331438 | Aylott et al. | Dec 2001 | B1 |
| 6362011 | Massey et al. | Mar 2002 | B1 |
| 6395558 | Duveneck et al. | May 2002 | B1 |
| 6399295 | Kaylor et al. | Jun 2002 | B1 |
| 6399397 | Zarling et al. | Jun 2002 | B1 |
| 6411439 | Nishikawa | Jun 2002 | B2 |
| 6416952 | Pirrung et al. | Jul 2002 | B1 |
| 6423465 | Hawker et al. | Jul 2002 | B1 |
| 6436651 | Everhart et al. | Aug 2002 | B1 |
| 6448091 | Massey et al. | Sep 2002 | B1 |
| 6455861 | Hoyt | Sep 2002 | B1 |
| 6468741 | Massey et al. | Oct 2002 | B1 |
| 6556299 | Rushbrooke et al. | Apr 2003 | B1 |
| 6573040 | Everhart et al. | Jun 2003 | B2 |
| 6579673 | McGrath et al. | Jun 2003 | B2 |
| 6582930 | Ponomarev et al. | Jun 2003 | B1 |
| 6613583 | Richter et al. | Sep 2003 | B1 |
| 6653151 | Anderson et al. | Nov 2003 | B2 |
| 6743581 | Vo-Dinh | Jun 2004 | B1 |
| 6790531 | Fournier | Sep 2004 | B2 |
| 6844028 | Mao et al. | Jan 2005 | B2 |
| 20020028243 | Masters | Mar 2002 | A1 |
| 20020028455 | Laibinis et al. | Mar 2002 | A1 |
| 20030027327 | Cunningham et al. | Feb 2003 | A1 |
| 20030207253 | Kaylor et al. | Nov 2003 | A1 |
| 20030207254 | Cohen et al. | Nov 2003 | A1 |
| 20030207255 | Cohen et al. | Nov 2003 | A1 |
| 20030207257 | Cohen et al. | Nov 2003 | A1 |
| 20030207258 | Cohen et al. | Nov 2003 | A1 |
| 20040002110 | Boga et al. | Jan 2004 | A1 |
| 20040058385 | Abel et al. | Mar 2004 | A1 |
| 20040063146 | Sayre et al. | Apr 2004 | A1 |
| 20050013751 | Huang et al. | Jan 2005 | A1 |
| Number | Date | Country |
|---|---|---|
| 0205698 | Dec 1986 | EP |
| 0420053 | Apr 1991 | EP |
| 0453820 | Oct 1991 | EP |
| 0453820 | Oct 1991 | EP |
| 0453820 | Oct 1991 | EP |
| 0539035 | Apr 1993 | EP |
| 0539035 | Apr 1993 | EP |
| 0596421 | May 1994 | EP |
| 0657737 | Jun 1995 | EP |
| 0657737 | Jun 1995 | EP |
| 1566627 | Aug 2005 | EP |
| 2273772 | Jun 1994 | GB |
| 9403496 | Feb 1974 | WO |
| 9005305 | May 1990 | WO |
| 9105999 | May 1991 | WO |
| WO 9113998 | Sep 1991 | WO |
| WO 9413835 | Jun 1994 | WO |
| 9415193 | Jul 1994 | WO |
| WO 9609532 | Mar 1996 | WO |
| 9615193 | May 1996 | WO |
| WO 9612962 | May 1996 | WO |
| 9626435 | Aug 1996 | WO |
| WO 9624062 | Aug 1996 | WO |
| 9629629 | Sep 1996 | WO |
| 9633971 | Oct 1996 | WO |
| WO 9301308 | Jan 1998 | WO |
| 9810334 | Mar 1998 | WO |
| WO 9815831 | Apr 1998 | WO |
| 9827417 | Jun 1998 | WO |
| WO 9910742 | Mar 1999 | WO |
| WO 9930131 | Jun 1999 | WO |
| WO 9931486 | Jun 1999 | WO |
| WO 0050891 | Aug 2000 | WO |
| WO 0171322 | Sep 2001 | WO |
| WO 0181921 | Nov 2001 | WO |
| WO 0181921 | Nov 2001 | WO |
| Number | Date | Country | |
|---|---|---|---|
| 20080026454 A1 | Jan 2008 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 10139013 | May 2002 | US |
| Child | 11800538 | US |
